ENTA
Enanta Pharmaceuticals Inc
Price:  
5.11 
USD
Volume:  
177,346.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA WACC - Weighted Average Cost of Capital

The WACC of Enanta Pharmaceuticals Inc (ENTA) is 9.4%.

The Cost of Equity of Enanta Pharmaceuticals Inc (ENTA) is 8.15%.
The Cost of Debt of Enanta Pharmaceuticals Inc (ENTA) is 108.05%.

Range Selected
Cost of equity 6.80% - 9.50% 8.15%
Tax rate 1.90% - 2.50% 2.20%
Cost of debt 7.00% - 209.10% 108.05%
WACC 6.8% - 11.9% 9.4%
WACC

ENTA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.64 0.83
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.50%
Tax rate 1.90% 2.50%
Debt/Equity ratio 0.01 0.01
Cost of debt 7.00% 209.10%
After-tax WACC 6.8% 11.9%
Selected WACC 9.4%